In 2017 and 2019, the German Institute for Quality and Efficiency in Health Care (IQWiG) had already examined the advantages and disadvantages of ribociclib in combination with an aromatase inhibitor or fulvestrant in comparison ...
Jun 5, 2020
0
3
With the help of a mandibular advancement device (MAD), daytime sleepiness of patients with obstructive sleep apnoea can be relieved. Treatment with an MAD is not inferior to positive airway pressure (PAP) therapy with a ...
Jun 3, 2020
0
0
In complex operations, is there a correlation between the volume of service provided per hospital and the quality of the treatment outcome? This question is addressed in eight commissions on minimum volumes that the Federal ...
May 22, 2020
0
0
On behalf of the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether it is meaningful to test newborns in Germany for spinal muscular atrophy (SMA) in combination ...
Apr 6, 2020
0
0
In elective surgery, does the likelihood of treatment success depend on how often the hospital or the medical team performs the intervention? This is the question addressed in eight commissions on minimum volumes awarded ...
Apr 2, 2020
0
0
In complex surgery, does a correlation exist between the volume of services provided per hospital or per surgeon and the quality of the treatment results? This is the question addressed in eight commissions on minimum volumes ...
Feb 19, 2020
0
2
Hypophosphatasia (HPP) is a rare congenital metabolic disorder. The frequency of severe courses of disease is estimated at 1:100 000: A deficiency of the enzyme phosphatase results in insufficient mineralization of the bones ...
Jan 27, 2020
0
4
Particularly in the case of accelerated drug approvals and drugs for rare diseases (orphan drugs), the evidence available at the time of market access is often insufficient for the early benefit assessment of drugs. Often, ...
Jan 24, 2020
0
1
In the summer of 2019, larotrectinib was approved as the first drug in Europe to be used in numerous different solid tumours if the tumour tissue displays a so-called NTRK gene fusion. Since such a fusion of a neurotrophic ...
Jan 16, 2020
0
1
In early July, the German Institute for Quality and Efficiency in Health Care (IQWiG) conducted two early benefit assessments to investigate whether certain drug combinations with pembrolizumab have advantages in comparison ...
Sep 20, 2019
0
0
